# Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer Prevention

> **NCT05338307** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 20 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** R-1,3-Butanediol

## Key facts

- **NCT ID:** NCT05338307
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-05-13
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05338307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05338307, "Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer Prevention". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05338307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*